 |
市场调查报告书
商品编码
1390672
重组 DNA 技术市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测Recombinant DNA Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
||||||
价格
抽象的
2022年全球重组DNA技术市场规模达7,298亿美元。展望未来， IMARC Group预计到2028年市场规模将达到9,668亿美元，2022-2028年复合年增长率（CAGR）为4.80%。
重组 DNA 技术的出现彻底改变了生物学的发展，并为创新提供了新的机会。它也称为基因工程，目前广泛用于改变生物体外部的遗传物质，并在活生物体中获得改进的和所需的特性。它包括透过适当的载体插入具有所需基因序列的多个来源的 DNA 片段。除此之外，它还有助于安全、经济且充足地生产饮食和对抗健康问题所需的重要蛋白质。因此，它具有多学科应用和改善健康、增强食物资源和抵抗不同不利环境影响的巨大潜力。
重组DNA技术市场趋势：
重组DNA技术主要透过开发新的疫苗和药物来改善不同的健康状况。再加上诊断试剂盒、监测设备和新治疗方法的开发而改进的治疗策略，是推动市场成长的关键因素之一。此外，对基因改造生物（GMO）的研究增加，其中包括被视为生物降解者和清洁燃料生产者的微生物。这可以归因于快速的城市化、全球人口的增长、耕地的减少、粮食短缺的严重加剧以及基改作物的日益采用。除此之外，重组DNA技术为医学遗传学和生物医学领域开发多种具有即时效果的治疗产品提供了多种创新机会，其应用正在各个领域不断扩大。例如，将重组 DNA 技术与有效基因疗法结合，以正常基因取代有缺陷的基因，以及生产用于临床研究、研究和疾病诊断的抗原特异性抗体，预计将在未来几年推动市场成长。
本报告回答的关键问题：
- 迄今为止，全球重组 DNA 技术市场表现如何，未来几年又将如何表现？
- COVID-19 对全球重组 DNA 技术市场有何影响？
- 主要区域市场有哪些？
- 基于产品的市场区隔是什么？
- 基于组件的市场区隔是什么？
- 基于应用程式的市场区隔是什么？
- 基于最终用户的市场区隔是什么？
- 产业价值链的各个阶段是什么？
- 该行业的关键驱动因素和挑战是什么？
- 全球重组DNA技术市场的结构如何？谁是主要参与者？
- 产业竞争程度如何？
目录
第一章：前言
第 2 章：范围与方法
- 研究目的
- 利害关係人
- 资料来源
- 主要资源
- 二手资料
- 市场预测
- 自下而上的方法
- 自上而下的方法
- 预测方法
第 3 章：执行摘要
第 4 章：简介
- 概述
- 主要行业趋势
第 5 章：全球重组 DNA 技术市场
- 市场概况
- 市场业绩
- COVID-19 的影响
- 市场预测
第 6 章：按产品分類的市场区隔
- 医疗的
- 市场走向
- 关键环节
- 治疗剂
- 人类蛋白质
- 疫苗
- 市场预测
- 非医疗
- 市场走向
- 关键环节
- 生物技术作物
- 特种化学品
- 其他的
- 市场预测
第 7 章：按成分分類的市场区隔
- 表达系统
- 市场走向
- 市场预测
- 克隆载体
- 市场走向
- 市场预测
第 8 章：按应用分類的市场区隔
- 食品和农业
- 市场走向
- 市场预测
- 健康与疾病
- 市场走向
- 市场预测
- 环境
- 市场走向
- 市场预测
- 其他的
- 市场走向
- 市场预测
第 9 章：最终用户的市场区隔
- 生物技术和製药公司
- 市场走向
- 市场预测
- 学术和政府研究机构
- 市场走向
- 市场预测
- 其他的
- 市场走向
- 市场预测
第 10 章：按地区分類的市场细分
- 北美洲
- 美国
- 市场走向
- 市场预测
- 加拿大
- 市场走向
- 市场预测
- 美国
- 亚太
- 中国
- 市场走向
- 市场预测
- 日本
- 市场走向
- 市场预测
- 印度
- 市场走向
- 市场预测
- 韩国
- 市场走向
- 市场预测
- 澳洲
- 市场走向
- 市场预测
- 印尼
- 市场走向
- 市场预测
- 其他的
- 市场走向
- 市场预测
- 中国
- 欧洲
- 德国
- 市场走向
- 市场预测
- 法国
- 市场走向
- 市场预测
- 英国
- 市场走向
- 市场预测
- 义大利
- 市场走向
- 市场预测
- 西班牙
- 市场走向
- 市场预测
- 俄罗斯
- 市场走向
- 市场预测
- 其他的
- 市场走向
- 市场预测
- 德国
- 拉丁美洲
- 巴西
- 市场走向
- 市场预测
- 墨西哥
- 市场走向
- 市场预测
- 其他的
- 市场走向
- 市场预测
- 巴西
- 中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测
第 11 章：SWOT 分析
- 概述
- 优势
- 弱点
- 机会
- 威胁
第 12 章：价值链分析
第 13 章：波特五力分析
- 概述
- 买家的议价能力
- 供应商的议价能力
- 竞争程度
- 新进入者的威胁
- 替代品的威胁
第 14 章：价格分析
第15章：竞争格局
- 市场结构
- 关键参与者
- 关键参与者简介
- Amgen Inc
- Cibus
- F.Hoffmann-La Roche Ltd
- GenScript
- GlaxoSmithKline plc.
- Horizon Discovery Group plc
- Merck KGaA
- New England Biolabs
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
- Syngene International Ltd (Biocon Limited)
Product Code: SR112023A4484
Abstract
The global recombinant DNA technology market size reached US$ 729.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 966.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.80% during 2022-2028.
The advent of recombinant DNA technology has revolutionized development in biology and offered new opportunities for innovations. Also known as genetic engineering, it is currently widely used to alter genetic material outside an organism and obtain improved and desired characteristics in living organisms. It includes the insertion of DNA fragments from several sources that have a desirable gene sequence through an appropriate vector. Besides this, it assists in the safe, affordable, and sufficient production of vital proteins required for dietary purposes and fighting health problems. As a result, it has multidisciplinary applications and a remarkable potential to improve health and enhance food resources and resistance to divergent adverse environmental effects.
Recombinant DNA Technology Market Trends:
The recombinant DNA technology is utilized for improving different health conditions, mainly by developing new vaccines and pharmaceuticals. This, coupled with the improving treatment strategies on account of the developing diagnostics kits, monitoring devices, and new therapeutic approaches, represents one of the key factors impelling the growth of the market. Moreover, there is a rise in the research conducted on genetically modified organisms (GMO), which include microorganisms that are considered as bio degraders and clean fuel producers. This can be accredited to rapid urbanization, growing global population, reducing arable land, considerable rising food shortage and increasing adoption of GMO crops. Apart from this, as recombinant DNA technology offers several innovation opportunities to develop a vast range of therapeutic products with immediate effect in medical genetics and biomedicine, its application is expanding in various sectors. For instance, the integration of recombinant DNA technology with effective gene therapy for replacing the defective gene with normal ones and the production of antigen-specific antibodies for clinical research, studies, and disease diagnosis, are anticipated to drive the market growth in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant DNA technology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, component, application and end user.
Breakup by Product:
Medical
Therapeutic Agent
Human Protein
Vaccines
Non-Medical
Biotech Crops
Specialty Chemicals
Others
Breakup by Component:
Expression System
Cloning Vector
Breakup by Application:
Food and Agriculture
Health and Disease
Environment
Others
Breakup by End User:
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A and Syngene International Ltd (Biocon Limited).
Key Questions Answered in This Report:
- How has the global recombinant DNA technology market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global recombinant DNA technology market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the component?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global recombinant DNA technology market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Recombinant DNA Technology Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Medical
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Therapeutic Agent
- 6.1.2.2 Human Protein
- 6.1.2.3 Vaccines
- 6.1.3 Market Forecast
- 6.2 Non-Medical
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Biotech Crops
- 6.2.2.2 Specialty Chemicals
- 6.2.2.3 Others
- 6.2.3 Market Forecast
7 Market Breakup by Component
- 7.1 Expression System
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Cloning Vector
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Food and Agriculture
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Health and Disease
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Environment
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by End User
- 9.1 Biotechnology and Pharmaceutical Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Academic and Government Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Amgen Inc
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Cibus
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 F.Hoffmann-La Roche Ltd
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 SWOT Analysis
- 15.3.4 GenScript
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 GlaxoSmithKline plc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Horizon Discovery Group plc
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Merck KGaA
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 New England Biolabs
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Novo Nordisk A/S
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Pfizer Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Sanofi S.A
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 Syngene International Ltd (Biocon Limited)
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.1 Amgen Inc
List of Figures
- Figure 1: Global: Recombinant DNA Technology Market: Major Drivers and Challenges
- Figure 2: Global: Recombinant DNA Technology Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Recombinant DNA Technology Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Recombinant DNA Technology Market: Breakup by Product (in %), 2022
- Figure 5: Global: Recombinant DNA Technology Market: Breakup by Component (in %), 2022
- Figure 6: Global: Recombinant DNA Technology Market: Breakup by Application (in %), 2022
- Figure 7: Global: Recombinant DNA Technology Market: Breakup by End User (in %), 2022
- Figure 8: Global: Recombinant DNA Technology Market: Breakup by Region (in %), 2022
- Figure 9: Global: Recombinant DNA Technology (Medical) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Recombinant DNA Technology (Medical) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Recombinant DNA Technology (Non-Medical) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Recombinant DNA Technology (Non-Medical) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Recombinant DNA Technology (Expression System) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Recombinant DNA Technology (Expression System) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Recombinant DNA Technology (Cloning Vector) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Recombinant DNA Technology (Cloning Vector) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Recombinant DNA Technology (Food and Agriculture) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Recombinant DNA Technology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Recombinant DNA Technology (Health and Disease) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Recombinant DNA Technology (Health and Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Recombinant DNA Technology (Environment) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Recombinant DNA Technology (Environment) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Recombinant DNA Technology (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Recombinant DNA Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Global: Recombinant DNA Technology (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Global: Recombinant DNA Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: North America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: North America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: United States: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: United States: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Canada: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Canada: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: Asia-Pacific: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: Asia-Pacific: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: China: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: China: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: Japan: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: Japan: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: India: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: India: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: South Korea: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: South Korea: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: Australia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: Australia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: Indonesia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: Indonesia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: Europe: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: Europe: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: Germany: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: Germany: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: France: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: France: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: United Kingdom: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: United Kingdom: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: Italy: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: Italy: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Spain: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Spain: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: Russia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: Russia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Latin America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Latin America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Brazil: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Brazil: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Mexico: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: Mexico: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Middle East and Africa: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 78: Middle East and Africa: Recombinant DNA Technology Market: Breakup by Country (in %), 2022
- Figure 79: Middle East and Africa: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 80: Global: Recombinant DNA Technology Industry: SWOT Analysis
- Figure 81: Global: Recombinant DNA Technology Industry: Value Chain Analysis
- Figure 82: Global: Recombinant DNA Technology Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Recombinant DNA Technology Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Recombinant DNA Technology Market Forecast: Breakup by Product (in Million US$), 2023-2028
- Table 3: Global: Recombinant DNA Technology Market Forecast: Breakup by Component (in Million US$), 2023-2028
- Table 4: Global: Recombinant DNA Technology Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 5: Global: Recombinant DNA Technology Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 6: Global: Recombinant DNA Technology Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 7: Global: Recombinant DNA Technology Market: Competitive Structure
- Table 8: Global: Recombinant DNA Technology Market: Key Players
